Your browser doesn't support javascript.
loading
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial.
Shefner, Jeremy M; Jacobsen, Bill; Kupfer, Stuart; Malik, Fady I; Meng, Lisa; Wei, Jenny; Wolff, Andrew A; Rudnicki, Stacy A.
Afiliação
  • Shefner JM; Barrow Neurological Institute, University of Arizona, and Creighton University, Phoenix, AZ, USA and.
  • Jacobsen B; Barrow Neurological Institute, University of Arizona, and Creighton University, Phoenix, AZ, USA and.
  • Kupfer S; Cytokinetics, Incorporated, South San Francisco, CA, USA.
  • Malik FI; Cytokinetics, Incorporated, South San Francisco, CA, USA.
  • Meng L; Cytokinetics, Incorporated, South San Francisco, CA, USA.
  • Wei J; Cytokinetics, Incorporated, South San Francisco, CA, USA.
  • Wolff AA; Cytokinetics, Incorporated, South San Francisco, CA, USA.
  • Rudnicki SA; Cytokinetics, Incorporated, South San Francisco, CA, USA.
Article em En | MEDLINE | ID: mdl-37641579

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Ano de publicação: 2024 Tipo de documento: Article